Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/463
DC FieldValueLanguage
dc.contributor.authorStanislava Nikolićen_US
dc.contributor.authorNikola Ćurićen_US
dc.contributor.authorBranislava Ilinčićen_US
dc.contributor.authorZoran Stošićen_US
dc.contributor.authorDragana Tomić Naglićen_US
dc.contributor.authorDamir Bencen_US
dc.date.accessioned2019-09-23T10:07:44Z-
dc.date.available2019-09-23T10:07:44Z-
dc.date.issued2019-03-01-
dc.identifier.issn428450en_US
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/463-
dc.description.abstract© 2019, Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved. Background/Aim. Numerous findings have indicated the potential relation between the osteocalcin, the traditional parameter of bone turnover and the regulation of energy metabolism. The aim of this study was to identify the relationship between osteocalcin and calculated indexes, which evaluate insulin sensitivity, insulin resistance and/or secretory capacity of the pancreas, in non-diabetic, obese subjects. Methods. The study included 57 (11 men and 46 women) euglycemic, obese patients (the body mass index – BMI: 41.03 ± 6.61 kg/m²) and 48 healthy individuals, age and sex matched (BMI: 23.15 ± 2.04 kg/m²). Plasma glucose and the insulin levels during the two-hour oral glucose tolerance test (OGTT) were determined in order to calculate the Homeostatic Model Assessment (HOMA) indexes (HOMA-IR, HOMA-B%), EISI (estimated insulin sensitivity index), EFP (estimated first phase) and ESP (estimated second phase). Osteocalcin was measured by using the Electro-chemiluminescence (ECLIA) methodology. Results. Statistically lower osteocalcin was found in the obese subjects (24.72 ± 9.80 vs 33.31 ± 10.89 ng/mL; p < 0.01). Тhere was a statistically significant positive correlation between osteocalcin and EISI (r = 0.340; p < 0.01). The inverse correlations were found between the osteocalcin and HOMA-IR (r =-0.276; p < 0.01), HOMA-B% (r =-0.337; p < 0.01), EFP (r =-0.332; p < 0.01) and ESP (r =-0.266; p < 0.01). Multiple regression showed that the BMI and osteocalcin have a significant inverse prediction with the EISI and HOMA-IR, but the level of prediction of the BMI was substantially higher. Conclusion. The effect of osteocalcin in the glycoregulation is evident, but its contribution is significantly smaller in relation to other obesity associated factors. Therefore, when assessing its position and the role in glycemic control it is always necessary to bear in mind that osteocalcin represents only one of the many contributing factors, some of which exhibit dominant influence than osteocalcin itself.en_US
dc.language.isoenen_US
dc.relation.ispartofVojnosanitetski Pregleden_US
dc.subjectobesityen_US
dc.subjectinsulin resistanceen_US
dc.subjectosteocalcinen_US
dc.subjectpancreasen_US
dc.subjectbody mass indexen_US
dc.titleRelation between osteocalcin and the energy metabolism in obesityen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.2298/VSP170328085N-
dc.identifier.scopus2-s2.0-85070762531-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85070762531-
dc.description.versionPublisheden_US
dc.relation.lastpage271en_US
dc.relation.firstpage266en_US
dc.relation.issue3en_US
dc.relation.volume76en_US
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptKatedra za patološku fiziologiju i laboratorijsku medicinu-
crisitem.author.deptKatedra za patološku fiziologiju i laboratorijsku medicinu-
crisitem.author.parentorgMedicinski fakultet-
crisitem.author.parentorgMedicinski fakultet-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

1
checked on Apr 29, 2023

Page view(s)

61
Last Week
5
Last month
7
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.